Changing trends in blood component utilisation during COVID time: Analysis of 1096 COVID-19 in patients

Introduction and Aim: In the global pandemic caused by Covid-19, older individuals and those with comorbidities have been shown to be more susceptible to serious diseases. The purpose of our research is to estimate the proportion of Covid-19 inpatients requiring blood transfusions over a period of 3 months.   Materials and Methods: A retrospective observational analysis of blood product consumption in Covid-19 inpatients at our center from April to June 2021 was conducted by reviewing monthly transfusion records archived in our blood bank.  Each blood component administered in Covid-19 wards during the prescribed period was noted.   Results: Out of 1096 Covid-19 inpatients, only 66 (6.02%) patients received transfusions. As compared to non-Covid wards, Covid-19 wards had substantially lower transfusion rates for packed cell units (84 vs. 1074 units), FFP (33 vs. 691 units), and platelets (46 vs. 595 units). A total of 163 units of blood components were given to 66 Covid-19 inpatients, the majority of which were packed cell units (51.5%).   Conclusion: In comparison to hospitalized non Covid patients, Covid-19 inpatients required fewer transfusions. In our institute, only the Covid 19 patients who were critically sick received blood transfusions; the rest received conservative therapy for their mild to moderate illnesses. This information will be beneficial for our department as it helps us plan and prepare for the use of blood supplies while the pandemic is still going strong.